Home/Filings/4/0000899243-21-006678
4//SEC Filing

Thakral Anshul 4

Accession 0000899243-21-006678

CIK 0001793294other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:14 PM ET

Size

14.2 KB

Accession

0000899243-21-006678

Insider Transaction Report

Form 4
Period: 2021-02-11
Thakral Anshul
EVP, Chief Commercial Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2021-02-11+32,894194,212 total
    Exercise: $10.59Exp: 2027-05-11Common Stock (32,894 underlying)
  • Award

    Stock Options (Right to Buy)

    2021-02-11+2,69930,849 total
    Exercise: $14.99Exp: 2028-12-14Common Stock (2,699 underlying)
  • Award

    Stock Options (Right to Buy)

    2021-02-11+4,60950,691 total
    Exercise: $21.70Exp: 2029-11-26Common Stock (4,609 underlying)
  • Award

    Stock Options (Right to Buy)

    2021-02-11+151,747151,747 total
    Exercise: $37.22Exp: 2031-02-11Common Stock (151,747 underlying)
Footnotes (5)
  • [F1]Represents previously awarded stock options vesting upon the achievement of certain EBITDA vesting conditions for fiscal 2020, which were determined to be earned subject to the receipt by the Issuer of the completed audit of its fiscal 2020 financial statements.
  • [F2]Represents 61,303 vested stock options and 132,909 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 29,907 stock options with an exercise price of $10.59 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal year 2021.
  • [F3]Represents 5,142 vested stock options and 25,707 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 7,711 stock options with an exercise price of $14.99 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2021-2023.
  • [F4]Represents 27,650 stock options of which 9,217 are vested and 18,433 of which are unvested and will vest in equal annual installments on November 26, 2021, November 26, 2022, November 26, 2023 and November 26, 2024 and 23,041 stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 18,432 stock options with an exercise price of $21.70 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2021-2024.
  • [F5]These options to purchase common stock vest with 122,624 vesting on the third anniversary of the grant date and 29,123 vesting in four equal installments beginning on the first anniversary of the grant date.

Issuer

PPD, Inc.

CIK 0001793294

Entity typeother

Related Parties

1
  • filerCIK 0001801747

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:14 PM ET
Size
14.2 KB